Factory Price Pharmaceutical Grade Capecitabine Powder CAS 154361 -50-9

Shipping Area
Worldwide/All Countries
CAS
154361-50-9
Assay
99%
Delivery Method
FedEx/DHL/Special Line
Product Name
Capecitabine
Service
Good Service
Storage
Keep in Cool and Dry Place
Test Method
HPLC
Delivery
Express 5-7 Days Arrive
Appearance
White Powder
Shelf Life
2 Years
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
200kg Per Month
Reference Price
$ 234.00 - 360.00
Contact Us

Product Description

Factory Price Pharmaceutical Grade Capecitabine Powder CAS 154361-50-9
Factory Price Pharmaceutical Grade Capecitabine Powder CAS 154361-50-9
Factory Price Pharmaceutical Grade Capecitabine Powder CAS 154361-50-9

Specification of Analysis

Product Name Capecitabine 
Appearance White powder
Molecular formula C15h22fn3o6
Molecular Weight 359.35
CAS 154361-50-9
Melting Point 110-121°C

What is  Capecitabine ?

Capecitabine is rapidly absorbed by the intestinal mucosa after oral administration, and then converted into an inactive  intermediate 5'-deoxy-5' fluorocytidine in the liver by carboxyl esterase, followed by cytidine removal from liver and  tumor tissues. The action of the aminoase is converted to 5'-deoxy-5' fluorouridine and finally catalyzed by thymidine  phosphorylase to fluorouracil (5-FU) in tumor tissues. Clinical studies have shown that the concentration of 5-FU in tumor tissue after oral administration is significantly  higher than that of blood and muscle. The efficacy of tumors in a variety of animals was significantly higher than 5-FU.

Function

1.Colorectal Cancer (either as neoadjuvant therapy with radiation, adjuvant therapy or for metastatic cases)
2.Breast cancer (Metastatic or as monotherapy/combotherapy, this is licensed as a second-line treatment in Uk)
3.Gastric Cancer (off-label  in the US, this is licensed indication in UK)
4.Oesophageal Cancer (off-label in US)

Application

Anticancer drugs are mainly used for non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

 

 
 
 
 
 
 

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023